Compare CNX & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNX | RDNT |
|---|---|---|
| Founded | 1860 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.5B |
| IPO Year | 1998 | 1996 |
| Metric | CNX | RDNT |
|---|---|---|
| Price | $38.29 | $59.74 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $35.71 | ★ $82.80 |
| AVG Volume (30 Days) | ★ 1.7M | 673.3K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 763.33 | N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | ★ $2,239,134,000.00 | $1,616,630,000.00 |
| Revenue This Year | N/A | $22.78 |
| Revenue Next Year | $11.14 | $10.70 |
| P/E Ratio | $17.52 | ★ N/A |
| Revenue Growth | ★ 76.76 | 13.05 |
| 52 Week Low | $27.72 | $50.79 |
| 52 Week High | $43.62 | $85.84 |
| Indicator | CNX | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 52.41 |
| Support Level | $37.42 | $58.46 |
| Resistance Level | $38.28 | $64.85 |
| Average True Range (ATR) | 1.01 | 3.04 |
| MACD | -0.01 | 0.36 |
| Stochastic Oscillator | 21.28 | 44.78 |
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.